trial · primary record
ALN-CIDEB
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 150 |
| Primary completion | 2029-01-29 |
| Primary endpoint | Percent change from baseline in liver fat by Magnetic Resonance Imaging-derived Proton Density Fat Fraction (MRI-PDFF) |
| Registry ID | NCT07631637 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:19.647Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07631637
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.